Aurinia Pharmaceuticals (AUPH) Cash & Equivalents Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn | -22.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.76% |
| Dec 31, 2025 | -5.21% |
| Sep 30, 2025 | -5.25% |
| Jun 30, 2025 | -29.56% |
| Mar 31, 2025 | -20.57% |
| Dec 31, 2024 | -28.88% |
| Sep 30, 2024 | -13.60% |
| Jun 30, 2024 | -34.98% |
| Mar 31, 2024 | -25.61% |
| Dec 31, 2023 | -43.59% |
| Sep 30, 2023 | -42.86% |
| Jun 30, 2023 | -29.42% |
| Mar 31, 2023 | -31.28% |
| Dec 31, 2022 | -32.49% |
| Sep 30, 2022 | -13.84% |
| Jun 30, 2022 | 4.86% |
| Mar 31, 2022 | -1.89% |
| Dec 31, 2021 | 25.27% |
| Sep 30, 2021 | -20.57% |
| Jun 30, 2021 | -2.78% |
| Mar 31, 2021 | 6.07% |
| Dec 31, 2020 | 18.03% |
| Sep 30, 2020 | 41.64% |
| Jun 30, 2020 | 8.95% |
| Mar 31, 2020 | 11.27% |
| Dec 31, 2019 | 97.62% |
| Sep 30, 2019 | 121.78% |
| Jun 30, 2019 | 143.35% |
| Mar 31, 2019 | 242.55% |
| Dec 31, 2018 | 173.66% |
| Sep 30, 2018 | 121.35% |
| Jun 30, 2018 | 79.95% |
| Mar 31, 2018 | -99.21% |